Effect of Acyclovir on HIV-1 Set Point among Herpes Simplex Virus Type 2-Seropositive Persons during Early HIV-1 Infection

被引:9
|
作者
Kim, H. Nina [1 ,4 ]
Wang, Jing [7 ]
Hughes, James [7 ]
Coombs, Robert [2 ,4 ,5 ]
Sanchez, Jorge [11 ]
Reid, Stewart [8 ,12 ]
Delany-Moretlwe, Sinead [13 ]
Cowan, Frances [14 ]
Fuchs, Jonathan [9 ,11 ]
Eshleman, Susan H. [10 ]
Khaki, Leila [7 ]
McMahon, Moira A. [10 ]
Siliciano, Robert F. [10 ]
Wald, Anna [4 ,7 ]
Celum, Connie [3 ,4 ,6 ]
机构
[1] Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98104 USA
[3] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98104 USA
[4] Univ Washington, Sch Publ Hlth, Dept Med, Seattle, WA 98104 USA
[5] Univ Washington, Sch Publ Hlth, Dept Lab Med, Seattle, WA 98104 USA
[6] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98104 USA
[7] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA
[8] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
[9] San Francisco Dept Publ Hlth, San Francisco, CA USA
[10] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[11] Asociac Civil Impacta Salud & Educ IMPACTA, Lima, Peru
[12] Ctr Infect Dis Res Zambia, Lusaka, Zambia
[13] Univ Witwatersrand, Reprod Hlth Unit, Johannesburg, South Africa
[14] UCL, London, England
来源
JOURNAL OF INFECTIOUS DISEASES | 2010年 / 202卷 / 05期
基金
美国国家卫生研究院;
关键词
REVERSE-TRANSCRIPTASE; SEROCONVERSION; ACQUISITION; RESISTANCE; MUTATION; COHORT; UGANDA; TRIAL; RAKAI; MEN;
D O I
10.1086/655662
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated whether acyclovir suppression during human immunodeficiency virus type 1 (HIV-1) acquisition reduces HIV-1 set point, increases CD4 cell counts, and selects reverse-transcriptase mutations among 76 HIV-1 seroconverters identified in a placebo-controlled trial of twice-daily acyclovir (400 mg) for the prevention of HIV acquisition in herpes simplex virus type 2 (HSV-2)-seropositive persons (HIV Prevention Trials Network study 039). We found no significant difference in plasma HIV-1 RNA levels (Pp. 30) or CD4 cell counts (Pp. 85) between the acyclovir and placebo recipients. V75I and other mutations in HIV-1 reverse transcriptase reported from in vitro acyclovir studies were not observed. In conclusion, acyclovir suppression during HIV-1 seroconversion and the subsequent 6 months does not affect HIV-1 set point.
引用
收藏
页码:734 / 738
页数:5
相关论文
共 50 条
  • [21] Precise Determination of Time to Reach Viral Load Set Point After Acute HIV-1 Infection
    Huang, Xiaojie
    Chen, Hui
    Li, Wei
    Li, Haiying
    Jin, Xia
    Perelson, Alan S.
    Fox, Zoe
    Zhang, Tong
    Xu, Xiaoning
    Wu, Hao
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (04) : 448 - 454
  • [22] Herpes Simplex Virus Type 2 Prevalence and Association with Inflammatory Cytokines Among Sexual and Gender Minorities Living With and Without HIV-1 from Lagos, Nigeria
    Aravantinou, Meropi
    Plagianos, Marlena
    Kokogho, Afoke
    Adebajo, Sylvia G.
    Nowak, Rebecca
    Shoyemi, Elizabeth
    Ekeh, Charles
    Lombardi, Kara A.
    Peel, Sheila D.
    Baral, Stefan A.
    Crowell, Trevor
    Derby, Nina
    Teleshova, Natalia
    Martinelli, Elena
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2023, 39 (09) : 485 - 494
  • [23] Herpes Simplex Virus Type-2 Shedding and Genital Ulcers During Early HIV in Zimbabwean Women
    Nowak, Rebecca G.
    Liska, Tobias A.
    Bentzen, Soren M.
    Kim, Esther
    Chipato, Tsungai
    Salata, Robert A.
    Celentano, David D.
    Morrison, Charles S.
    Gravitt, Patti E.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 87 (02) : 789 - 793
  • [24] RAPID GENERATION OF SEQUENCE VARIATION DURING PRIMARY HIV-1 INFECTION
    PANG, S
    SHLESINGER, Y
    DAAR, ES
    MOUDGIL, T
    HO, DD
    CHEN, ISY
    AIDS, 1992, 6 (05) : 453 - 460
  • [25] HIV-1 Transmission linkages among persons with incident infection to inform public health surveillance
    Dennis, Ann M.
    Frost, Simon D. W.
    Enders, Kimberly
    Cressman, Andrew E.
    Volz, Erik
    Adams, Nicole
    Miller, William C.
    Cohen, Myron S.
    Mobley, Victoria
    Samoff, Erika
    Eron, Joseph J.
    ECLINICALMEDICINE, 2021, 37
  • [26] Seroprevalence of herpes simplex virus type 1 among people living with HIV in Mbeya, Tanzania
    Issakwisa, Habakkuk Mwakyula
    Mbwile, Gloria Reginald
    Mbwanji, Godlove Fred
    Nassoro, David Daniel
    Ntinginya, Nyanda Elias
    Nsojo, Anthony Ambikile
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [27] Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda
    Phipps, Warren
    Nakku-Joloba, Edith
    Krantz, Elizabeth M.
    Selke, Stacy
    Huang, Meei-Li
    Kambugu, Fred
    Orem, Jackson
    Casper, Corey
    Corey, Lawrence
    Wald, Anna
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (03): : 439 - 447
  • [28] Evaluation of a Highly Sensitive Qualitative Human Immunodeficiency Virus Type 1 (HIV-1) RNA Assay for Detection of HIV-1 Suppression
    Nugent, C. Thomas
    Nodelman, Vladislav
    Giachetti, Cristina
    Richman, Douglas D.
    Looney, David J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (03) : 833 - 836
  • [29] Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas
    Hagan, H.
    Jenness, S. M.
    Wendel, T.
    Murrill, C. R.
    Neaigus, A.
    Gelpi-Acosta, C.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (08) : 580 - 583
  • [30] Development of a Multiplex Assay for Concurrent Diagnoses and Detection of HIV-1, HIV-2, and Recent HIV-1 Infection in a Single Test
    Yufenyuy, Ernest L.
    Parekh, Bharat S.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (12) : 1017 - 1027